Results of several studies in a murine model of estradiol-dependent breast carcinoma and human ER-positive IDC cell lines demonstrate that CAFs protect cancer cells from tamoxifen-induced cell death via activation of AKT and MAPK pathways, which leads to ER phosphorylation [32, 33, 35]. The gene discussed is ESR1; the disease is breast carcinoma.